KFP
CRBP icon

Keener Financial Planning’s Corbus Pharmaceuticals CRBP Stock Holding History

Keener Financial Planning’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6
Closed – – 196
2023
Q4 		$0 Buy
+6
New +$32 ﹤0.01% 180

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Keener Financial Planning's CRBP Position: Q1 2024 in Review

Keener Financial Planning sold out of Corbus Pharmaceuticals (CRBP) in Q1 2024, closing a stake of 6 shares.

Keener Financial Planning first reported a position in CRBP in Q4 2023 and held it in 1 quarter. The position peaked at $0 in Q4 2023. 82 funds tracked by Wall St. Rank hold CRBP as of Q1 2024.

  • Keener Financial Planning reported no remaining Corbus Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Keener Financial Planning sold 6 Corbus Pharmaceuticals shares in Q1 2024.
  • Keener Financial Planning first reported a position in Corbus Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Keener Financial Planning's Corbus Pharmaceuticals position peaked at $0 in Q4 2023.
  • 82 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2024.

Based on Keener Financial Planning's 13F filing for Q1 2024, filed 3 May 2024.